7Bardi A, Sapunar J, Oksexlirerg D, et al. Intrarenal arterial Doppler ultrasonography in cirrhosis patients with aseites, with and without hepatorenal syndrome. Rev Med Chil, 2002, 130: 173 - 180.
10Saner FH, Fruhauf NR,Schafers RF, et al. Terlipressin plus hydroxyethyl starch infusion: an effective treatment for hepatorenal syndrome. Eur J Gaslroenterol Hepatol, 2003 Aug, 15 (8) : 925 - 7.
二级参考文献28
1Soper CP, Latif AB, Bending MR. Amelioration of hepatorenal syndrome with selective endothelin-A antagonist. Lancet, 1996,347: 1842-1843.
2Duvoux C, Zanditenas D, Hezode C, et al. Noradrenaline for treatment of type lhepatorenal syndrome (HRS). J Hepatol, 2001, 34(Suppl.1): 18.
3Holt S, Goodier D, Marley R, et al. Improvement in renal function in hepatorenal syndrome with N-acetylcysteine. Lancet, 1999, 353:294-295.
4Daskalopoulos G. Randomized trial of peritoneovenous shunt (PVS)in the treatment of hepatorcnal syndrome (HRS). Gastroenterology,1995, 88: 88.
5Runyon BA. Management of adult patients with ascites caused by cirrhosis. Hepatology, 1998, 27: 264-272.
6Bilbao JI, Quiroga J, Herrero JI, et al. Transjugular intrahepatic portosystemic shunt (TIPS): current status and future possibilities.Cardiovasc Intervent Radiol, 2002, 25:251-269.
7Mitzner SR, Stange J, Klarmnt S, et al. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J Am Soc Nephrol, 2001, 12 (Suppl17): S75-82.
8Mitzner SR, Stange J, Klammt S, et al Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl,2000, 6: 277-286.
9Cassinello C, Moreno E, Gozalo A, et al. Effects of orthotopic liver transpiantation on vasoactive systems and renal function in patients with advanced liver cirrhosis. Dig Dis Sci, 2003, 48: 179-186.
10Gonwa TA, Klintmalm GB, Levy M, et al. Impact of pretransplant renal function on survival after liver transplantation.Transplantation, 1995, 59: 361-365.
4Ott P, Larsen FS. Blood-brain barrier permeability to ammonia in liver failure: a critical reappraisal, Neurochem Int, 2004, 44: 185- 198.
5Jalan R, Bernuau J. Induction of cerebral hyperemia by ammonia plus endotoxin: does hyperammonemia unlock the blood-brain barrier? J Hepatol, 2007, 47: 168-171.
6Arroyo V, Ginbs P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology, 1996, 23: 164-176.
7Cardenas A, Gines R Hepatorenal syndrome. Clin Liver Dis, 2006, 10: 371-385.
8Anand R, Harry D, Holt S, et al. Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure. Gut, 2002, 50: 111-117.
9Moreau R, Lebrec D. Acute kidney injury: new concepts. Hepatorenal syndrome: the role of vasopressors. Nephron Physiol, 2008, 109: p73-79.
10Gentilini P, La Villa G. Liver-kidney pathophysiological interrelationships in liver diseases. Dig Liver Dis, 2008, 40: 909-919.
